AI Powered R&D for Pulmonary Drug Delivery

We seek to leverage AI in two distinct embodiments. AI will provide valuable iterative input for research and development across all sectors of our system, while another AI engine will assist with dose delivery and monitoring of the patient condition.

A unique, proprietary drug delivery molecule is at the center of what we aim to achieve. We  anticipate our approach will contribute towards providing greater medication adherence and reduce disease state complications. 

The physical device in which we will package our AI-embedded drug delivery system will be state-of-the-art and is envisioned to possess integrated security features and communication capabilities to external biofeedback devices.